Hala Chaaban1, Troy A Markel2, Jennifer Canvasser3, Misty Good4. 1. Department of Pediatrics, Section of Neonatal-Perinatal Medicine, University of Oklahoma, Oklahoma City, OK, USA. 2. Department of Surgery, Section of Pediatric Surgery, The Indiana University School of Medicine, Indianapolis, IN, USA. 3. NEC Society, Davis, CA, USA. 4. Department of Pediatrics, Division of Newborn Medicine, Washington University School of Medicine, St. Louis, MO, USA. Electronic address: mistygood@wustl.edu.
Abstract
BACKGROUND: Necrotizing enterocolitis (NEC) is a devastating gastrointestinal disease that primarily affects premature infants. Despite medical advances, mortality and morbidity from NEC are still unacceptably high. This is partly because of the lack of specific biomarkers and therapies for this disease. Availability of high-quality biological samples and the associated data from premature infants are key to advance our understanding of NEC, and for biomarker discovery and drug development. To that end, the NEC Society Biorepository was established with the goal of promoting studies in human infants through sharing specialized biospecimen and data procurement for NEC research. OBJECTIVE: In this review, we will discuss the required infrastructure for biobanks, discuss the importance of informatics management, and emphasize the logistical requirements for sharing specimens. Finally, we will discuss the mechanism for how tissues and material will be shared between the institutions. CONCLUSION: We have developed a state-of-the-art biobank for human infants to advance the field of NEC research. With the NEC Society Biorepository, we seek to facilitate and accelerate the basic and translational studies on NEC to provide hope to the infants afflicted with NEC and their families. STUDY TYPE: Review article, level V.
BACKGROUND:Necrotizing enterocolitis (NEC) is a devastating gastrointestinal disease that primarily affects premature infants. Despite medical advances, mortality and morbidity from NEC are still unacceptably high. This is partly because of the lack of specific biomarkers and therapies for this disease. Availability of high-quality biological samples and the associated data from premature infants are key to advance our understanding of NEC, and for biomarker discovery and drug development. To that end, the NEC Society Biorepository was established with the goal of promoting studies in humaninfants through sharing specialized biospecimen and data procurement for NEC research. OBJECTIVE: In this review, we will discuss the required infrastructure for biobanks, discuss the importance of informatics management, and emphasize the logistical requirements for sharing specimens. Finally, we will discuss the mechanism for how tissues and material will be shared between the institutions. CONCLUSION: We have developed a state-of-the-art biobank for humaninfants to advance the field of NEC research. With the NEC Society Biorepository, we seek to facilitate and accelerate the basic and translational studies on NEC to provide hope to the infants afflicted with NEC and their families. STUDY TYPE: Review article, level V.
Authors: C Voegele; L Alteyrac; E Caboux; M Smans; F Lesueur; F Le Calvez-Kelm; P Hainaut Journal: Bioinformatics Date: 2010-08-31 Impact factor: 6.937
Authors: Lori D Campbell; Fay Betsou; Debra Leiolani Garcia; Judith G Giri; Karen E Pitt; Rebecca S Pugh; Katherine C Sexton; Amy P N Skubitz; Stella B Somiari Journal: Biopreserv Biobank Date: 2012-04 Impact factor: 2.300
Authors: P H J Riegman; W N M Dinjens; M H A Oomen; A Spatz; C Ratcliffe; K Knox; R Mager; D Kerr; F Pezzella; B van Damme; M van de Vijver; H van Boven; M M Morente; S Alonso; D Kerjaschki; J Pammer; J A Lopez-Guerrero; A Llombart Bosch; A Carbone; A Gloghini; I Teodorovic; M Isabelle; D Jaminé; A Passioukov; S Lejeune; P Therasse; E-B van Veen; K H Lam; J W Oosterhuis Journal: Eur J Cancer Date: 2006-10-05 Impact factor: 9.162